CN214880989U

CN214880989U - Complete set bio-pharmaceuticals effluent treatment plant

Info

Publication number: CN214880989U
Application number: CN202121445255.0U
Authority: CN
Inventors: 刘曦薇; 李冰晗; 李玉龙; 洪国强
Original assignee: Sinopharm Chongqing Pharmaceutical Industry Design Institute
Current assignee: Sinopharm Chongqing Pharmaceutical Industry Design Institute
Priority date: 2021-06-28
Filing date: 2021-06-28
Publication date: 2021-11-26
Anticipated expiration: 2031-06-28

Abstract

The utility model discloses a complete set bio-pharmaceuticals effluent treatment plant, including first collecting pit and second collecting pit, the delivery port of first collecting pit is connected to the water inlet in inactivation pond through first elevator pump, be provided with the steam inactivation ware in the inactivation pond in order to carry out the inactivation treatment to sewage, the overflow mouth in this inactivation pond with the water inlet of second collecting pit links to each other, the delivery port of second collecting pit is connected to the coagulating sedimentation pond through the second elevator pump, and the overflow mouth of this coagulating sedimentation pond loops through behind hydrolytic acidification pond, the biological contact oxidation pond and links to each other with the water inlet in sludge impoundment, the overflow mouth in sludge impoundment links to each other with the water inlet in disinfection pond, the sludge impoundment still through the mud back flow with the mud backward flow mouth in biological contact oxidation pond links to each other be provided with the sludge pump on the mud back flow. The remarkable effects are as follows: the sewage is purified by the sewage flowing automatically, so that the biopharmaceutical sewage with complex cost is purified gradually and better.

Description

Complete set bio-pharmaceuticals effluent treatment plant

Technical Field

The utility model relates to the technical field of wastewater treatment of biological pharmaceutical enterprises, in particular to a complete set of biological pharmaceutical wastewater treatment device.

Background

The biopharmaceutical technology, a high-tech technology, was developed in the early 70 s along with the invention and application of the DNA recombination technology and the lymphocyte hybridoma technology. The rapid development of the biological pharmaceutical technology opens up a wide prospect for the development of the medical industry and the pharmaceutical industry for more than thirty years, and greatly improves the life of people. Thus, biopharmaceuticals are identified in countries of the world as key technologies and emerging industries for the technological development of the 21 st century. However, the bio-pharmaceutical technology generates a large amount of sewage during operation, mainly including pilot plant production process wastewater, equipment cleaning wastewater, sanitary cleaning wastewater, research and development wastewater, quality inspection wastewater, animal house cleaning wastewater and domestic sewage.

The sewage is not only complicated in source and inconvenient in treatment, but also contains pathogen pollutants, oxygen-consuming pollutants, plant nutrients, toxic pollutants and the like, and cannot be directly discharged and applied, and the purpose of effective purification cannot be achieved by adopting the traditional sewage treatment mode. Therefore, how to treat the sewage generated in the biological pharmacy technology so as to change the sewage into valuable and even recycle the sewage becomes a problem to be solved by the technology.

Disclosure of Invention

The utility model aims to overcome the defects in the prior art and provide a complete set of biological pharmaceutical wastewater treatment device, which can satisfy the sewage self-flowing treatment and discharge to reach the standard, and has low operating cost.

In order to achieve the above purpose, the utility model adopts the following technical scheme:

the utility model provides a complete set bio-pharmaceuticals effluent treatment plant which the key lies in: including the first collecting pit that is used for collecting the fungus waste water and the second collecting pit that is used for collecting clean waste water, the delivery port of first collecting pit is connected to the water inlet in deactivation pond through first elevator pump, be provided with the steam inactivator in the deactivation pond in order to carry out the inactivation treatment to sewage, the overflow mouth in this deactivation pond with the water inlet of second collecting pit links to each other, the delivery port of second collecting pit is connected to the coagulating sedimentation pond through the second elevator pump, and the overflow mouth of this coagulating sedimentation pond loops through behind hydrolytic acidification pond, the biological contact oxidation pond and links to each other with the water inlet in sludge impoundment, the overflow mouth in sludge impoundment links to each other with the water inlet in disinfection pond, the sludge impoundment still through the mud back flow with the mud backward flow mouth in biological contact oxidation pond links to each other be provided with the sludge pump on the mud back flow.

Furthermore, liquid level sensors are arranged in the first collecting pool and the second collecting pool.

Furthermore, the liquid level sensor is one of a float type liquid level sensor, a static pressure type liquid level sensor and an ultrasonic type liquid level sensor.

Furthermore, the inside first coagulating sedimentation area and the second coagulating sedimentation area that divide into through the baffle of coagulating sedimentation pond, the water inlet setting of coagulating sedimentation pond is in first coagulating sedimentation area, the overflow mouth setting of coagulating sedimentation pond is in the second coagulating sedimentation area, first coagulating sedimentation area is linked together through the runner of baffle below with the second coagulating sedimentation area first coagulating sedimentation area and second coagulating sedimentation area all are provided with agitating unit.

Furthermore, the stirring device comprises a stirring motor and a stirring shaft connected with an output shaft of the stirring motor, and a plurality of layers of stirring blades are arranged at the lower part of the stirring shaft.

Further, hydrolysis-acidification pond is inside to divide into one-level hydrolysis-acidification district and second grade hydrolysis-acidification district through first filter screen, the water inlet setting in hydrolysis-acidification pond is in one-level hydrolysis-acidification district, be linked together through the runner that is located first filter screen below between one-level hydrolysis-acidification district and the second grade hydrolysis-acidification district, the overflow mouth setting in hydrolysis-acidification pond is in second grade hydrolysis-acidification district.

Further, biological contact oxidation pond inside divide into one-level contact oxidation district and second grade contact oxidation district through the second filter screen, biological contact oxidation pond's water inlet and mud backward flow mouth set up in one-level contact oxidation district, be linked together through the runner that is located the second filter screen below between one-level contact oxidation district and the second grade contact oxidation district, biological contact oxidation pond's overflow mouth set up in second grade contact oxidation district all be provided with blast aeration mechanism on one-level contact oxidation district and the second grade contact oxidation district.

The utility model discloses a show the effect and be:

the device can gradually and better purify the biopharmaceutical sewage with complex cost by gradually treating the inactivation tank, the coagulating sedimentation tank, the hydrolysis acidification tank, the biological contact oxidation tank, the sludge tank and the disinfection tank, and can effectively purify the wastewater with complex components compared with the prior art that single purification equipment or process is adopted for purification;

the device has good technical advancement, applicability, reliability and high cost performance, carries out purification treatment and discharge up to standard through sewage self-flowing, reduces the operating cost and is easy to popularize and implement.

Drawings

Fig. 1 is a schematic structural diagram of the present invention.

Detailed Description

The following provides a more detailed description of the embodiments and the operation of the present invention with reference to the accompanying drawings.

As shown in figure 1, a set of bio-pharmaceutical wastewater treatment device comprises a first collection tank 1 for collecting bacteria-containing wastewater and a second collection tank 4 for collecting clean wastewater, wherein a water outlet of the first collection tank 1 is connected to a water inlet of an inactivation tank 3 through a first lift pump 2, a steam inactivator is arranged in the inactivation tank 3 for inactivating sewage, an overflow port of the inactivation tank 3 is connected with a water inlet of the second collection tank 4, a water outlet of the second collection tank 4 is connected to a coagulation sedimentation tank 6 through a second lift pump 5, an overflow port of the coagulation sedimentation tank 6 is connected with a water inlet of a sludge tank 9 after sequentially passing through a hydrolysis acidification tank 7 and a biological contact oxidation tank 8, an overflow port of the sludge tank 9 is connected with a water inlet of a disinfection tank 10, and the sludge tank 9 is further connected with a sludge return port of the biological contact oxidation tank 8 through a sludge return pipe 91, a sludge pump 92 is provided to the sludge return pipe 91.

Referring to fig. 1, liquid level sensors 11 are arranged in the first collecting tank 1 and the second collecting tank 4; further, the liquid level sensor 11 is one of a float type liquid level sensor, a static pressure type liquid level sensor, and an ultrasonic type liquid level sensor.

Set up level sensor 11 and carry out liquid level monitoring to can provide the warning and with the linkage function of elevator pump, and then realize that the elevator pump is automatic to be opened and stop, reach and need not personnel on duty. When the high liquid level exceeds the warning liquid level, the sound and light alarm can be carried out on the personnel in the workshop.

In this example, in order to ensure the chemical precipitation effect and to ensure that suspended matters, total phosphorus and acute toxicity are effectively removed, the interior of the coagulation sedimentation tank 6 is divided into a first coagulation sedimentation zone 61 and a second coagulation sedimentation zone 62 by a partition plate 63, the water inlet of the coagulation sedimentation tank 6 is arranged in the first coagulation sedimentation zone 61, the overflow port of the coagulation sedimentation tank 6 is arranged in the second coagulation sedimentation zone 62, the first coagulation sedimentation zone 61 and the second coagulation sedimentation zone 62 are communicated by a flow passage below the partition plate 63, and a stirring device 64 is arranged in each of the first coagulation sedimentation zone 61 and the second coagulation sedimentation zone 62.

Preferably, the stirring device 64 includes a stirring motor 641 and a stirring shaft 642 connected to an output shaft of the stirring motor, and a plurality of layers of stirring blades 643 are provided at a lower portion of the stirring shaft 642.

In this example, in order to guarantee the biochemical treatment effect, to ensure that abundant utilization hydrolytic bacteria, acidizing bacteria hydrolyze the water insoluble organic matter into soluble organic matter, turn into the process of the easy biodegradable micromolecule material with the macromolecular material of difficult biodegradable to provide good water quality environment for follow-up biochemical treatment, hydrolytic acidification tank 7 is inside to divide into one-level hydrolytic acidification district 72 and second grade hydrolytic acidification district 73 through first filter screen 71, the water inlet setting of hydrolytic acidification tank 7 is in one-level hydrolytic acidification district 72, be linked together through the runner that is located first filter screen 71 below between one-level hydrolytic acidification district 72 and the second grade hydrolytic acidification district 73, the overflow mouth setting of hydrolytic acidification tank 7 is in second grade hydrolytic acidification district 73.

In this example, in order to ensure the biochemical treatment effect and ensure that the organic substances in the state of dissolved and colloidal substances in the wastewater are sufficiently degraded and converted into harmless substances, the inside of the biological contact oxidation tank 8 is divided into a primary contact oxidation area 82 and a secondary contact oxidation area 83 by a second filter screen 81, the water inlet and sludge return port of the biological contact oxidation tank 8 are arranged in the primary contact oxidation area 82, the primary contact oxidation area 82 and the secondary contact oxidation area 83 are communicated by a flow channel below the second filter screen 81, the overflow port of the biological contact oxidation tank 8 is arranged in the secondary contact oxidation area 83, the primary contact oxidation area 82 and the secondary contact oxidation area 83 are both provided with a blast aeration mechanism 84, and the air outlet of the blast aeration mechanism 84 is positioned at the bottom of the biological contact oxidation tank 8, and the sewage is oxygenated by the blast aeration mechanism 84, and the sewage in the tank body is in a flowing state so as to ensure that the sewage is fully contacted with the filler in the sewage and avoid the defect of uneven contact between the sewage and the filler in the biological contact oxidation tank 8.

In the wastewater treatment process, because the pilot plant process wastewater, the equipment cleaning wastewater and the research and development and analysis detection laboratory wastewater in the bio-pharmaceutical production contain germs, the germs need to be collected separately and can be mixed with other wastewater after being subjected to inactivation treatment. That is, the bacteria-containing wastewater and the bacteria-free clean wastewater generated in the production are respectively collected by the first collecting tank 1 and the second collecting tank 4, and the bacteria-containing wastewater in the first collecting tank 1 is introduced into the inactivation tank 3 for inactivation treatment by the first lift pump 2, and then is sent into the second collecting tank 4.

In this case, the inactivation is preferably performed by using a steam inactivator. The steam inactivator can be used in laboratory and production scale pasteurization processes. The special pasteurization device is specially designed for various fluid products, and is particularly suitable for products with high viscosity and weak fluidity. Automatic control, degree of automation is high, desktop design, product elegant appearance, equipment operation is stable, the quality is reliable, easy operation is convenient, does not need other external equipment, the full simulation industrial production, experimental data is accurate, can directly put industrial production.

Then, as the wastewater in the bio-pharmaceutical production belongs to high-concentration organic wastewater, the COD value is usually as high as 11000mg/L, and the contents of total nitrogen, total phosphorus and suspended matters are also high. The discharge standard clearly provides total nitrogen, total phosphorus and fecal coliform group and requirements, and the discharge limit value is low. For quick, high-efficient removal pollutants, this embodiment adopts the waste water in the second collecting pit 4 to pass through chemical precipitation pretreatment process through the coagulating sedimentation pond 6 of second elevator pump 5, gets rid of suspended solid, total phosphorus, acute toxicity.

Meanwhile, because the wastewater has better biochemical property, the biochemical treatment mode in the hydrolysis acidification tank 7 and the biological contact oxidation tank 8 is adopted as the secondary treatment of the production wastewater, and the wastewater is sent into a sludge tank after the biochemical treatment is finished. The biochemical treatment is to degrade and convert the dissolved and colloidal organic matters in the wastewater into harmless substances by utilizing the metabolism function of microorganisms, so that the wastewater is purified.

In the process, in order to ensure better biochemical treatment effect and ensure that the wastewater can be fully purified, the sludge in the sludge tank can be sent into the biological contact oxidation tank 8 through the sludge return pipe by the sludge pump for secondary treatment.

And finally, sending the upper clear water in the sludge tank into a disinfection tank 10 for disinfection treatment, and then discharging after reaching the standard.

The sludge at the bottom layer of the sludge tank can be subjected to filter pressing and then sent to an environmental sanitation part for further purification treatment or sent to other environmental protection companies for resource utilization.

This device is through deactivation pond 3, coagulating sedimentation tank 6, hydrolysis-acidification tank 7, biological contact oxidation pond 8, sludge impoundment 9 and disinfection pond 10 progressively handle the back, can make the biopharmaceutical sewage that contains the complex cost obtain progressively, purify better, compare and adopt single clarification plant or technology to purify among the prior art, and it can purify the pharmaceutical waste water that the composition is complicated effectively.

The technical scheme provided by the utility model is introduced in detail above. The principles and embodiments of the present invention have been explained herein using specific examples, and the above descriptions of the embodiments are only used to help understand the method and its core ideas of the present invention. It should be noted that, for those skilled in the art, without departing from the principle of the present invention, the present invention can be further modified and modified, and such modifications and modifications also fall within the protection scope of the appended claims.

Claims

1. The utility model provides a complete set bio-pharmaceuticals effluent treatment plant which characterized in that: including the first collecting pit that is used for collecting the fungus waste water and the second collecting pit that is used for collecting clean waste water, the delivery port of first collecting pit is connected to the water inlet in deactivation pond through first elevator pump, be provided with the steam inactivator in the deactivation pond in order to carry out the inactivation treatment to sewage, the overflow mouth in this deactivation pond with the water inlet of second collecting pit links to each other, the delivery port of second collecting pit is connected to the coagulating sedimentation pond through the second elevator pump, and the overflow mouth of this coagulating sedimentation pond loops through behind hydrolytic acidification pond, the biological contact oxidation pond and links to each other with the water inlet in sludge impoundment, the overflow mouth in sludge impoundment links to each other with the water inlet in disinfection pond, the sludge impoundment still through the mud back flow with the mud backward flow mouth in biological contact oxidation pond links to each other be provided with the sludge pump on the mud back flow.

2. The biopharmaceutical wastewater processing apparatus of claim 1, wherein: and liquid level sensors are arranged in the first collecting pool and the second collecting pool.

3. The biopharmaceutical wastewater processing apparatus of claim 2, wherein: the liquid level sensor adopts one of a float type liquid level sensor, a floating ball type liquid level sensor, a static pressure type liquid level sensor and an ultrasonic liquid level sensor.

4. The biopharmaceutical wastewater processing apparatus of claim 1, wherein: the coagulating sedimentation tank is internally divided into a first coagulating sedimentation area and a second coagulating sedimentation area through a partition plate, a water inlet of the coagulating sedimentation tank is arranged in the first coagulating sedimentation area, an overflow port of the coagulating sedimentation tank is arranged in the second coagulating sedimentation area, the first coagulating sedimentation area is communicated with the second coagulating sedimentation area through a flow channel below the partition plate, and stirring devices are arranged in the first coagulating sedimentation area and the second coagulating sedimentation area.

5. The biopharmaceutical wastewater processing apparatus of claim 4, wherein: the stirring device comprises a stirring motor and a stirring shaft connected with an output shaft of the stirring motor, and a plurality of layers of stirring blades are arranged at the lower part of the stirring shaft.

6. The biopharmaceutical wastewater processing apparatus of claim 1, wherein: the hydrolysis acidification pond is inside to be divided into one-level hydrolysis acidification district and second grade hydrolysis acidification district through first filter screen, the water inlet setting in the hydrolysis acidification pond is in one-level hydrolysis acidification district, be linked together through the runner that is located first filter screen below between one-level hydrolysis acidification district and the second grade hydrolysis acidification district, the overflow mouth setting in hydrolysis acidification pond is in second grade hydrolysis acidification district.

7. The biopharmaceutical wastewater processing apparatus of claim 1, wherein: biological contact oxidation pond inside divide into one-level contact oxidation district and second grade contact oxidation district through the second filter screen, biological contact oxidation pond's water inlet and sludge reflux mouth set up in one-level contact oxidation district, be linked together through the runner that is located second filter screen below between one-level contact oxidation district and the second grade contact oxidation district, biological contact oxidation pond's overflow mouth set up in second grade contact oxidation district all be provided with blast air aeration mechanism on one-level contact oxidation district and the second grade contact oxidation district.